[Initial clinical results of N-(3-isoamyloxy, 2-(3,4,5-trimethoxy) benzoyloxy) propyl tetrahydro 1,4-oxazine hydrochloride on coronary pain and disorders of rhythm].
D000328:Adult; D000368:Aged; D000777:Anesthetics; D000787:Angina Pectoris / Q000188:drug therapy*; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D003327:Coronary Disease / Q000188:drug therapy*; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010078:Oxazines / Q000494:pharmacology / Q000627:therapeutic use*
D000777:Anesthetics; D000889:Anti-Arrhythmia Agents; D010078:Oxazines
Premiers résultats cliniques du N-(3-isoamyloxy, 2(3,4,5-triméthoxy) benzoyloxy) propyl tétrahydro 1,4-oxazine, chlorhydrate sur les douleurs coronariennes et les troubles du rythme.